Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials
Sign Up to like & getrecommendations! Published in 2021 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2021.2015761
Abstract: Abstract Objective Oral hypoglycemic drugs for the treatment of gestational diabetes mellitus (GDM) are still controversial because they can pass through the placenta. The purpose of this meta-analysis is to evaluate the safety and effectiveness… read more here.
Keywords: safety; hypoglycemic drugs; insulin; oral hypoglycemic ... See more keywords
Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled study in Japan (PREFERENCE 4 study)
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.12659
Abstract: To compare the treatment satisfaction of four classes of oral hypoglycemic agents (OHAs): dipeptidyl peptidase‐4 (DPP‐4) inhibitors, α‐glucosidase inhibitors (αGI), biguanides (BG) and sulfonylureas (SU), which are common initial treatments for type 2 diabetes mellitus… read more here.
Keywords: hypoglycemic agents; oral hypoglycemic; treatment satisfaction; study ... See more keywords
Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
Sign Up to like & getrecommendations! Published in 2017 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-017-0220-4
Abstract: BackgroundRandomized clinical trials have shown the efficacy and safety of short-acting exenatide in patients with type 2 diabetes mellitus (T2DM). The aim of this observational study was to investigate the effectiveness and safety of exenatide… read more here.
Keywords: controlled oral; safety; study; oral hypoglycemic ... See more keywords
Reducing the burden of diabetes treatment: A review of low-cost oral hypoglycemic medications.
Sign Up to like & getrecommendations! Published in 2020 at "Current diabetes reviews"
DOI: 10.2174/1573399816666200206112318
Abstract: BACKGROUND The vast majority of individuals diagnosed with diabetes are low/middle income and may have access to only three of the 11 oral hypoglycemic medications (OHMs) due to cost: metformin intermediate release (IR) or extended… read more here.
Keywords: pioglitazone; hypoglycemic medications; low cost; oral hypoglycemic ... See more keywords
Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy—A Cross-Sectional Study in Patients with Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph20054623
Abstract: Objective: This study investigated the effect of amino acid metabolism on the risk of diabetic nephropathy under different conditions of the diabetic retinopathy, and the use of different oral hypoglycemic agents. Methods: This study retrieved… read more here.
Keywords: diabetic retinopathy; risk diabetic; diabetic nephropathy; oral hypoglycemic ... See more keywords